Evommune, Inc.
EVMN
$14.65
$0.584.12%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.00M | 10.00M | 13.00M | 13.00M | 3.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.00M | 10.00M | 13.00M | 13.00M | 3.00M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 10.00M | 10.00M | 13.00M | 13.00M | 3.00M |
| SG&A Expenses | 28.12M | 22.99M | 20.03M | 14.34M | 13.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 111.89M | 99.99M | 94.07M | 85.81M | 79.00M |
| Operating Income | -101.89M | -89.99M | -81.07M | -72.81M | -76.00M |
| Income Before Tax | -94.67M | -75.99M | -68.87M | -61.32M | -64.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -94.67 | -75.99 | -68.87 | -61.32 | -64.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -94.67M | -75.99M | -68.87M | -61.32M | -64.76M |
| EBIT | -101.89M | -89.99M | -81.07M | -72.81M | -76.00M |
| EBITDA | -100.36M | -88.63M | -79.68M | -71.39M | -74.55M |
| EPS Basic | -11.04 | -18.95 | -27.79 | -40.91 | -43.30 |
| Normalized Basic EPS | -6.90 | -11.85 | -17.37 | -24.95 | -26.45 |
| EPS Diluted | -11.04 | -18.95 | -27.79 | -40.91 | -43.30 |
| Normalized Diluted EPS | -6.90 | -11.85 | -17.37 | -24.95 | -26.45 |
| Average Basic Shares Outstanding | 91.13M | 56.53M | 24.40M | 6.15M | 6.12M |
| Average Diluted Shares Outstanding | 91.13M | 56.53M | 24.40M | 6.15M | 6.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |